tenk.fyi

LENZ Therapeutics, Inc.

LENZNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$19.1M

Net Income

-$82.1M

65.0% YoY

EPS

$-2.85

21.8% YoY

Cash

$25.2M

24.9% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro